Lack of association of the genotype in the GNAS fok i polymorphism and prostate cancer

Urologia Internationalis

Volumn 87, Issue 1, 2011, Pages 80-86

  Eisenhardt, A ^a,b   Scherag, A ^b   Jockel K H ^b   Reis, H ^b   Rubben H ^b   Siffert, W ^c  

^a Praxisklinik Urologie Rhein Ruhr ^*  (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

G protein coupled signal transduction; Genetic marker; Prostate cancer susceptibility; Single nucleotide polymorphism

Indexed keywords

ADULT; AGED; ARTICLE; DNA EXTRACTION; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GNAS GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION MAPPING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GERMANY; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051801385     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000325398     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006.
2. CA Cancer J Clin 2006; 56: 106-130.
3. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Isaacs WB, International Consortium for Prostate Cancer Genetics: Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 2007; 6: 1271-1278. (Pubitemid 47055123)
4. Stanford JL, FitzGerald LM, McDonnell SK, Carlson EE, McIntosh LM, Deutsch K, Hood L, Ostrander EA, Schaid DJ: Dense genomewide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Hum Mol Genet 2009; 18: 1839-1848.
5. Neale BM, Sham PC: The future of association studies: Gene-based analysis and replication. Am J Hum Genet 2004; 75: 353-362. (Pubitemid 39095812)
6. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell D: Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996; 56: 4108.
7. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW: Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 166.
8. Blazer DG, Umbach DM, Bostick RM, Taylor JA: Vitamin D receptor polymorphisms and prostate cancer. Mol Carcinog 2000; 27: 18.
9. Berndt SI, Dodson JL, Huang WY, Nicodemus KK: A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J Urol 2006; 175: 1613-1623.
10. Hadaschik BA, Sowery RD, Gleave ME: Novel targets and approaches in advanced prostate cancer. Curr Opin Urol 2007; 17: 182-187. (Pubitemid 46597438)
11. Srivastava RK, Srivastava AR, Cho-Chung YS, Longo DL: Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells. Oncogene 1999; 18: 1755-1763. (Pubitemid 29137466)
12. Yan L, Herrmann V, Hofer JK, Insel PA: Beta-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol 2000; 279:C1665-C1674.
13. Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC, et al: Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol 1999; 180: 71-80. (Pubitemid 29249714)
14. Oldham WM, Hamm HE: Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 2008; 9: 60-71.
15. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ: Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 1991; 60: 653-688.
16. Yang X, Lee FY Sr, Wand GS: Increased expression of Gs(a) enhances activation of the adenylyl cyclase signal transduction cascade. Mol Endocrinol 1997; 11: 1053-1061. (Pubitemid 27278828)
17. Krumins AM, Barber R: Examination of the effects of increasing Gs protein on b2-adrenergic receptor, Gs, and adenylyl cyclase interactions. Biochem Pharmacol 1997; 54: 61-72. (Pubitemid 27353222)
18. Frey U, Eisenhardt A, Lümmen G, Rübben H, Jöckel KH, Siffert W: The T393C polymorphism of the Gas gene (GNAS1) is a novel predictive and prognostic marker for bladder cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 871-877. (Pubitemid 40478550)
19. Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG, Jöckel KH, Siffert W, Schmid KW: GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer. Clin Cancer Res 2005; 11: 5071-5077. (Pubitemid 41003689)
20. Frey UH, Lümmen G, Jäger T, Jöckel KH, Schmid KW, Rübben H, Müller N, Siffert W, Eisenhardt A: The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res 2006; 12: 759-763. (Pubitemid 43259855)
21. Lehnerdt GF, Franz P, Winterhoff S, Bankfalvi A, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH: The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope 2008; 118: 2172-2176.
22. Frey UH, Nückel H, Sellmann L, Siemer D, Küpers R, Dürig J, Dührsen U, Siffert W: The GNAS1 T393C polymorphism and survival in chronic lymphocytic leukemia. Clin Cancer Res 2006; 12: 5686-5692.
23. Watanabe M, Hirokawa Y, Tsui M, Yanagawa M, Murata T, Suzuki H, Ichikawa T, Katoh T, Sugimura Y, Shiraishi T: Lack of involvement of the GNAS1 T393C polymorphism in prostate cancer risk in a Japanese population. Anticancer Res 2008; 28: 3711-3716.
24. Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, Catalona WJ: Genetic prostate cancer risk assessment: Common variants in nine genomic regions are associated with cumulative risk. J Urol 2010; 184: 501-505.
25. Sobin LH, Fleming ID: TNM Classification of Malignant Tumors, ed 5. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804.
26. Siffert W, Forster P, Jöckel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P Heyns A, Epplen JT, Fridey J, Freedman BI, Müller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D: Worldwide ethnic distribution of the G protein b3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999; 10: 1921-1930. (Pubitemid 29402513)
27. Wigginton JE, Cutler DJ, Abecasis GR: A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 887-893. (Pubitemid 40563110)
28. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT: Cancer control with radical prostatectomy for prostate cancer. J Urol 2002; 167: 528-534. (Pubitemid 34074521)
29. Otterbach F, Callies R, Frey UH, Schmitz KJ, Wreczycki C, Kimmig R, Siffert W, Schmid KW: The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma. Breast Cancer Res Treat 2007; 105: 311-317. (Pubitemid 47596451)
30. Dehm SM, Tindall DJ: Molecular regulation in prostate cancer. J Cell Biochem 2006; 99: 333-344.
31. Cancel-Tassin, Cussenot O: Genetic susceptibility to prostate cancer. BJU Int 2005; 96: 1380-1385.
32. Chen J, Iyengar R: Suppression of Ras-induced transformation of NIH 3T3 cells by activated Gas. Science 1994; 263: 1278-1281.
33. Cook SJ, McCormick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993; 262: 1069-1072. (Pubitemid 24035049)